Concepedia

Elevated serum fibroblast growth factor 23 levels as an indicator of lower extremity atherosclerotic disease in Chinese patients with type 2 diabetes mellitus

Xingxing He, Xiang Hu, Xiaojing Ma, Hang Su, Lingwen Ying, Jiahui Peng, Xiaoping Pan, Yuqian Bao, Jian Zhou, Weiping Jia

Cardiovascular Diabetology · 2017 · 31 citations · 29 references

Open access

References

29

Standards of Medical Care in Diabetes—2010

Diabetes Care · 2009 · 3.4K citations · Full text

Diabetes Management, Health Policy, Diabetes +2

Circulating Fibroblast Growth Factor-23 Is Associated With Fat Mass and Dyslipidemia in Two Independent Cohorts of Elderly Individuals

Majd A.I. Mirza, Johan Alsiö, Ann Hammarstedt et al. · Arteriosclerosis Thrombosis and Vascular Biology · 2010 · 173 citations · Full text

FGF-23 as a Predictor of Renal Outcome in Diabetic Nephropathy

Silvia Titan, Roberto Zatz, Fabiana G. Graciolli et al. · Clinical Journal of the American Society of Nephrology · 2010 · 149 citations · Full text

Fibroblast Growth Factor‐23 and Incident Coronary Heart Disease, Heart Failure, and Cardiovascular Mortality: The Atherosclerosis Risk In Communities Study

Pamela L. Lutsey, Álvaro Alonso, Elizabeth Selvin et al. · Journal of the American Heart Association · 2014 · 132 citations · Full text

Presentations of major peripheral arterial disease and risk of major outcomes in patients with type 2 diabetes: results from the ADVANCE-ON study

Cardiovascular Diabetology · 2016 · 116 citations · Full text